Skip to main navigation Skip to search Skip to main content

Estudio sobre la consolidación ósea de defectos críticos, mediante el uso de plasma rico en factores de crecimiento gelificado

Student thesis: Doctoral thesis

Abstract

In orthopedic surgery, strategies are currently being sought for the generation of biomaterials that accelerate the consolidation of bone defects of critical size in long bones, taking into account that if they are not treated adequately they can lead to pseudoarthrosis and consequently non-functionality. of the affected limb, which could end in amputation, thus interfering with the quality of life of the patients. Cell therapy with plasma rich in growth factors (PRGF) has become a research material, with the aim of allowing the growth factors that are stored in the α granules of these cells to be released efficiently and at high rates. quantities in the implanted site, which will accelerate the bone consolidation process. The preparation of the PRGF in our study was carried out with the Endoret® protocol, which is based on a single centrifugation with the BTI® PRGF System III centrifuge, at 460 gaus for 8 minutes, the platelets were activated with 10% calcium chloride, at a proportion of 5% of the activator in relation to the amount of PRGF obtained, finally its preparation allows the adequate concentration of growth factors such as PDGF, TGFβ, IGF, VGF, FGF, EGF, HGF and VEGF, which have the function of accelerating tissue repair processes. The PRGF we used in our preclinical study was allowed to gel at room temperature for 30 minutes. The gelled PRGF was implanted in 20mm critical bone defects in the middle third of the tibia of 12 New Zealand breed rabbits, and there was a control group of 12 experimental animals in which no biomaterial was implanted. The osteosynthesis method used to stabilize the tibia was a biplanar external skeletal fixator. The assessment of the analgesic effect produced by PRGF was carried out during the first 15 post-surgical days. The evaluation of the osteogenesis produced in the critical defects was carried out at 8, 15, 30 and 60 days after surgery by means of radiographic analysis and computed axial tomography through the assessment of bone formation with the modified Lane radiological scoring scale. and Sandhu and according to the radiographic criteria of the modified mRUST (Radiographic Union in Tibia) score and the TUS score (Tomographic Union Score). At 15, 30 and 60 days after surgery, qualitative assessment was carried out with histological analysis and quantitative assessment of bone formation with histomorphometric analysis. In parallel, the assessment of two bone biomarkers, osteopontin and type I collagen, was carried out. Our results show that there are statistically significant differences between the group treated with gelled PRGF and the control group, taking into account that the treated group presented greater bone neoformation in the critical defect in each period evaluated and completely closing the defect 60 days postoperatively with evidence of bone remodeling.
Date of Award11 Apr 2025
Original languageSpanish
SupervisorFelix Angel Garcia Arnas (Director) & Jose Maria Carrillo Poveda (Director)

Cite this

'